Published in Neuroimage on June 01, 1994
Randomised Controlled Trial of Memantine in Fibromyalgia | NCT01653457
Computational psychiatry as a bridge from neuroscience to clinical applications. Nat Neurosci (2016) 1.04
Ant Colony Optimization Based Feature Selection Method for QEEG Data Classification. Psychiatry Investig (2014) 1.01
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues Clin Neurosci (2008) 0.99
Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) (2004) 0.93
Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. Neuropsychopharmacology (2012) 0.89
An herbal nasal drop enhanced frontal and anterior cingulate cortex activity. Evid Based Complement Alternat Med (2011) 0.84
Multiweek resting EEG cordance change patterns from repeated olfactory activation with two constitutionally salient homeopathic remedies in healthy young adults. J Altern Complement Med (2012) 0.80
Electroencephalography and analgesics. Br J Clin Pharmacol (2014) 0.80
The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data. Eur Arch Psychiatry Clin Neurosci (2014) 0.76
A wavelet-based technique to predict treatment outcome for Major Depressive Disorder. PLoS One (2017) 0.75
Neural Network Based Response Prediction of rTMS in Major Depressive Disorder Using QEEG Cordance. Psychiatry Investig (2015) 0.75
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.68
Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.51
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci (2000) 6.54
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology (2008) 3.54
A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc (2001) 3.20
The spectrum of behavioral changes in Alzheimer's disease. Neurology (1996) 2.97
Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry (1999) 2.89
Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex (2001) 2.88
Subcortical dementia. Review of an emerging concept. Arch Neurol (1984) 2.65
Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci (1994) 2.59
Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging (2002) 2.46
Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45
Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology (1991) 2.43
Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 2.28
Apathy is not depression. J Neuropsychiatry Clin Neurosci (1998) 2.24
Thirty-one human adenovirus serotypes (Ad1-Ad31) form five groups (A-E) based upon DNA genome homologies. Virology (1979) 2.14
Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 2.07
Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry (2001) 2.04
Preparation and characterization of highly radioactive in vitro labeled adenovirus DNA and DNA restriction fragments. Biochemistry (1977) 2.04
Quasiperiodicity and chaos in cardiac fibrillation. J Clin Invest (1997) 1.99
Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology. Br J Psychiatry (1986) 1.96
The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol (1996) 1.94
The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci (1997) 1.93
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry (2000) 1.93
Visual hallucinations. Clinical occurrence and use in differential diagnosis. West J Med (1987) 1.91
Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc (1998) 1.88
The temporal variant of frontotemporal dementia. Brain (1997) 1.76
Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease. Int Psychogeriatr (2001) 1.72
Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex (1998) 1.70
Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology (1994) 1.67
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry (2006) 1.67
Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology (2011) 1.66
Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2000) 1.62
The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry (2000) 1.61
Utilization of Alzheimer's disease community resources by Asian-Americans in California. Int J Geriatr Psychiatry (2000) 1.56
Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size, and leuko-araiosis. Arch Neurol (1988) 1.54
Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc (1992) 1.51
Asymptomatic degenerative disk disease and spondylosis of the cervical spine: MR imaging. Radiology (1987) 1.51
The insistent call from functional MRI. Neurology (1997) 1.50
Chondroid tumors of the larynx: computed tomography findings. Am J Otolaryngol (2000) 1.50
Encephalitis lethargica: lessons for contemporary neuropsychiatry. J Neuropsychiatry Clin Neurosci (1995) 1.49
Depression in epilepsy. Significance and phenomenology. Arch Neurol (1986) 1.48
Neuropsychiatric disturbances associated with idiopathic calcification of the basal ganglia. Biol Psychiatry (1983) 1.48
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol (1983) 1.47
The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry (2000) 1.46
A unique pattern of integrated viral genes in hamster cells transformed by highly oncogenic human adenovirus 12. Cell (1976) 1.45
Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease. Int J Clin Pract (2015) 1.43
Neuropsychiatric aspects of progressive supranuclear palsy. Neurology (1996) 1.41
Handgun control: a public health imperative. AJNR Am J Neuroradiol (1992) 1.40
Sneddon's syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence. Neurology (1995) 1.40
Functional correlates of musical and visual ability in frontotemporal dementia. Br J Psychiatry (2000) 1.40
Handgun control: a public health issue. AJR Am J Roentgenol (1992) 1.39
Ranulas and their mimics: CT evaluation. Radiology (1987) 1.39
Atypical Pneumocystis carinii pneumonia in homosexual men with unusual immunodeficiency. AJR Am J Roentgenol (1982) 1.39
Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord (2000) 1.39
Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5, and 6) human adenoviruses. Proc Natl Acad Sci U S A (1979) 1.39
Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope (1995) 1.38
New approach to the synthesis of polyribonucleotides of defined sequence. Nature (1971) 1.38
MR imaging findings after transplant surgery for Parkinson disease. J Magn Reson Imaging (1994) 1.38
Assessment of cerebral perfusion using quantitative EEG cordance. Psychiatry Res (1994) 1.38
Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord (1999) 1.37
Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology (2002) 1.37
Kluver-Bucy syndrome in Pick disease: clinical and pathologic correlations. Neurology (1981) 1.37
Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol (2001) 1.37
Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol (2001) 1.34
Repetitive and compulsive behavior in frontal lobe degenerations. J Neuropsychiatry Clin Neurosci (1994) 1.33
Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci (2000) 1.31
MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging (1999) 1.31
Evaluating dementia screening tests: methodologic standards to rate their performance. Neurology (1999) 1.30
Frequency of dementia in Parkinson disease. Arch Neurol (1996) 1.30
Aggressive, socially disruptive and antisocial behaviour associated with fronto-temporal dementia. Br J Psychiatry (1997) 1.30
Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol (1987) 1.29
Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci (1999) 1.29
Idiopathic basal ganglia calcification and organic mood disorder. Am J Psychiatry (1988) 1.26
Managing psychosis in patients with Parkinson's disease. N Engl J Med (1999) 1.26
Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry (1996) 1.24
Anomalies of digastric muscles: CT and MR demonstration. J Comput Assist Tomogr (1987) 1.24
Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology (1993) 1.23
The human Klüver-Bucy syndrome. Neurology (1983) 1.22
Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings. Arch Neurol (1995) 1.21
Frontal-subcortical circuits: the anatomic basis of executive, social and motivated behaviors. J Psychopharmacol (1997) 1.21
Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology (2009) 1.20
Babesiosis in man: a case from Scotland. Br Med J (1979) 1.19
Risk factors for depression in Parkinson disease. Arch Neurol (1997) 1.18
Phonagnosia: a dissociation between familiar and unfamiliar voices. Cortex (1988) 1.18
A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry (1993) 1.17
Amnesia with hippocampal lesions after cardiopulmonary arrest. Neurology (1984) 1.17
Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment. Acta Psychiatr Scand (2010) 1.16
Mutism: review, differential diagnosis, and report of 22 cases. Am J Psychiatry (1986) 1.16
Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1997) 1.15
A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology (1997) 1.14
Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology (2000) 1.14